Search research articles
Contact Us
Filters
Showing results (41-50 of 78) with videos related to
Page
of 8
Sort By:
Cancer Letters
|
July 19, 2019
Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma
Joseph J Caumanns, Anne van Wijngaarden, Arjan Kol, et al.
Journal of Personalized Medicine
|
April 30, 2021
The <i>BRAF</i> P.V600E Mutation Status of Melanoma Lung Metastases Cannot Be Discriminated on Computed Tomography by LIDC Criteria nor Radiomics Using Machine Learning
Lindsay Angus, Martijn P A Starmans, Ana Rajicic, et al.
Molecular Imaging and Biology
|
October 4, 2022
Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry Calculations
Joyce van Sluis, Walter Noordzij, Elisabeth G E de Vries, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 3, 2024
Everolimus decreases [U-<sup>13</sup>C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo
Gerke Ariaans, Jiske F Tiersma, Bernardus Evers, et al.
Neuro-Oncology Practice
|
January 28, 2022
Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
Annemarie C Eggen, Nadine M Richard, Ingeborg Bosma, et al.
Journal of Pain and Symptom Management
|
March 8, 2020
Death Anxiety in Patients With Metastatic Non-Small Cell Lung Cancer With and Without Brain Metastases
Annemarie C Eggen, Anna K L Reyners, Gerald Shen, et al.
Journal for Immunotherapy of Cancer
|
September 19, 2020
Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort
Sonja Levy, Maureen J B Aarts, Ferry A L M Eskens, et al.
Melanoma Research
|
December 13, 2017
Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform
Cornelis Bisschop, Arja Ter Elst, Lisette J Bosman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 10, 2021
<sup>18</sup>F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
Pieter H Nienhuis, Inês F Antunes, Andor W J M Glaudemans, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 31, 2019
Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program
Cornelis Bisschop, Thijs T Wind, Christian U Blank, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 78) with videos related to
Sort By:
Page
of 8
Cancer Letters
|
July 19, 2019
Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma
Joseph J Caumanns, Anne van Wijngaarden, Arjan Kol, et al.
Journal of Personalized Medicine
|
April 30, 2021
The <i>BRAF</i> P.V600E Mutation Status of Melanoma Lung Metastases Cannot Be Discriminated on Computed Tomography by LIDC Criteria nor Radiomics Using Machine Learning
Lindsay Angus, Martijn P A Starmans, Ana Rajicic, et al.
Molecular Imaging and Biology
|
October 4, 2022
Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry Calculations
Joyce van Sluis, Walter Noordzij, Elisabeth G E de Vries, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 3, 2024
Everolimus decreases [U-<sup>13</sup>C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo
Gerke Ariaans, Jiske F Tiersma, Bernardus Evers, et al.
Neuro-Oncology Practice
|
January 28, 2022
Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
Annemarie C Eggen, Nadine M Richard, Ingeborg Bosma, et al.
Journal of Pain and Symptom Management
|
March 8, 2020
Death Anxiety in Patients With Metastatic Non-Small Cell Lung Cancer With and Without Brain Metastases
Annemarie C Eggen, Anna K L Reyners, Gerald Shen, et al.
Journal for Immunotherapy of Cancer
|
September 19, 2020
Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort
Sonja Levy, Maureen J B Aarts, Ferry A L M Eskens, et al.
Melanoma Research
|
December 13, 2017
Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform
Cornelis Bisschop, Arja Ter Elst, Lisette J Bosman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 10, 2021
<sup>18</sup>F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
Pieter H Nienhuis, Inês F Antunes, Andor W J M Glaudemans, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 31, 2019
Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program
Cornelis Bisschop, Thijs T Wind, Christian U Blank, et al.
Page
of 8